Human Epidemiology of Newly Identified Arboviruses
- Conditions
- Arbovirus InfectionsSARS-CoV Infection
- Registration Number
- NCT04954352
- Lead Sponsor
- University Hospital, Montpellier
- Brief Summary
A local network is being set up to study the impact of arboviruses in our region. It is committed to a one-health approach, in particular with research without a priori for new viruses hosted among vectors and wildlife. The candidates identified by high throughput sequencing approaches will serve as a basis for the development of serological and molecular tools for their detections. These tools will be used to assess the possible circulation of these new viruses in humans in biological collections created within the framework of this project Arbodocc
.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 400
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Seroprevalence 1 day Detection of antibodies targeting specific antigens of newly identified arboviruses
- Secondary Outcome Measures
Name Time Method Molecular detection 1 day Detection of newly identified arboviruses genome
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Uh Montpellier
🇫🇷Montpellier, France
Uh Montpellier🇫🇷Montpellier, FranceVincent Foulongne, PHDContact467 330 254v-foulongne@chu-montpellier.frSérafin GuttierezSub InvestigatorMarc EloitSub InvestigatorYannick SimoninSub Investigator